Descripción de la oferta
At Genmab, we are dedicated to building extra[not]ordinary® futures, together, by developing antibody products and groundbreaking, knock-your-socks-off KYSO antibody medicines® that change lives and the future of cancer treatment and serious diseases. We strive to create, champion and maintain a global workplace where individuals' unique contributions are valued and drive innovative solutions to meet the needs of our patients, care partners, families and employees.Our people are compassionate, candid, and purposeful, and our business is innovative and rooted in science. We believe that being proudly authentic and determined to be our best is essential to fulfilling our purpose. Yes, our work is incredibly serious and impactful, but we have big ambitions, bring a ton of care to pursuing them, and have a lot of fun while doing so.Does this inspire you and feel like a fit? Then we would love to have you join us!Genmab is strengthening its presence in Europe and expanding its commercial capabilities to bring innovative medicines to more patients. As pioneers in antibody biology and innovation, we are seeking a driven and talented individual to help deliver our cutting-edge oncology treatments to patients across Spain. If you're passionate about oncology, bring experience from both large pharmaceutical organizations and nimble biotech environments, and with a deep expertise of the Spanish market access & pricing landscape, we want to hear from you!The RoleGenmab is preparing to launch a new innovation in cervical cancer in Europe. In this role, you will lead development of the Spanish Market Access strategy for the company's oncology pipeline. Specifically, the Market access strategy, pricing and public affairs director will lead efforts in assessing and communicating to internal and external stakeholders the market access requirements of Spain for oncology, contributing to and shaping the overall value strategy for our brands throughout lifecycle. The position will drive development of local market access strategy, delivery of HTA submissions, and lead P&R negotiations. In this role, the director will have also to develop and implement a strong public affairs plan in collaboration with the General Manager.ResponsibilitiesIdentify, analyse, develop, and implement recommendations and strategies regarding P&R policy and challenges important to company's product portfolio;Analyse, synthesize, and translate technical P&R information, including coverage and reimbursement policies, into meaningful decision points, recommendations, and strategic tactics;Champion the P&R requirements for Spanish Commercial Operations throughout commercialization and ensure alignment between all stakeholders internally as to prioritized needs;Contribute to strategy discussions and communication efforts with relevant external stakeholders including key government agencies and organizations;Partner in development of European and global value access & pricing deliverables, working in close collaboration with European and global colleagues and external vendors as needed;Drive development of Spanish market access deliverables including HTA submissions; local evidence generation plans; negotiation strategies, and country-level regional and local market access tactics to secure reimbursement;Develop HTA payer and advocacy engagement plans and other external experts;Maintain alignment of local market access strategy to European and Global Market Access Strategy; establish pricing position within EU Price Brand;Collaborate closely with relevant internal stakeholders, including Marketing, Medical Affairs, Regulatory, etc.Requirements10 to 15 years of experience within the field of Market Access & pricing. Experience in Health Economics and Outcomes Research is a plus;Strong network of relevant stakeholders in Spain;Strong knowledge of the market access & pricing landscape;Strong oncology market knowledge from a commercial and clinical studies perspective;Excellent communication and negotiation skills;Business fluency in English;Fluency in local language is a must .In order to be considered please apply with a English resume.The proposed gross annual base salary range for this position, in the primary location, based on a full time schedule is:EUR84.000,00---126.000,00The final salary offer will depend on several factors, including your skills, qualifications, and experience.In addition to base salary, this position is eligible for additional forms of compensation, such as discretionary bonuses and long-term incentives.When you join Genmab, you become a part of a culture that supports your physical, financial, social, and emotional well-being. Our benefits include, but are not limited to:PensionHealth insurance and wellness benefitsPaid time offEmployee support programsFurther details on eligibility for compensation and benefits based on the role will be provided during the recruitment process.About GenmabGenmab is an international biotechnology company with a core purpose to improve the lives of patients through innovative and differentiated antibody therapeutics. For 25 years, its hard-working, innovative and collaborative team has invented next-generation antibody technology platforms and harnessed translational, quantitative and data sciences, resulting in a proprietary pipeline including bispecific T-cell engagers, antibody-drug conjugates, next-generation immune checkpoint modulators and effector function-enhanced antibodies. By 2030, Genmab's vision is to transform the lives of people with cancer and other serious diseases with Knock-Your-Socks-Off (KYSO®) antibody medicines.Established in 1999, Genmab is headquartered in Copenhagen, Denmark with international presence across North America, Europe and Asia Pacific. For more information, please visit Genmab.com and follow us on LinkedIn and X .Genmab is committed to protecting your personal data and privacy. Please see our privacy policy for handling your data in connection with your application on our website Job Applicant Privacy Notice (genmab.com) .Please note that if you are applying for a position in the Netherlands, Genmab's policy for all permanently budgeted hires in NL is initially to offer a fixed-term employment contract for a year, if the employee performs well and if the business conditions do not change, renewal for an indefinite term may be considered after the contract.
